{"result":[{"lastName":"Warnke","clinicalFocus":[{"focus":"Anatomic/Clinical Pathology"},{"focus":"Pathology and Laboratory Medicine"}],"appointments":[{"appointment":"Emeritus (Active) Professor,Pathology"},{"appointment":"Emeritus Faculty, Acad Council,Pathology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Emeritus (Active) Professor,Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=3786&type=small&showNoImage","displayName":"Roger Warnke","firstName":"Roger","href":"http://med.stanford.edu/profiles/Roger_Warnke","researchInterest":"The research in my laboratory involves the application of monoclonal and polyclonal antibodies and a variety of immunohistochemical methods to study human B-cell, T-cell, accessory cell and related neoplasms."},{"lastName":"Arber","clinicalFocus":[{"focus":"Anatomic/Clinical Pathology"},{"focus":"Hematopathology"},{"focus":"Pathology"}],"appointments":[{"appointment":"Professor - Med Center Line,Pathology"}],"primaryAppointment":"Professor - Med Center Line,Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=3925&type=small&showNoImage","displayName":"Daniel A. Arber, M.D.","firstName":"Daniel","href":"http://med.stanford.edu/profiles/Daniel_Arber","researchInterest":"I study molecular genetic and immunophenotypic changes in human hematopoietic neoplasms. These include acute and chronic leukemias, lymphoma, and splenic tumors."},{"lastName":"Tibshirani","clinicalFocus":[],"appointments":[{"appointment":"Professor,Health Research & Policy - Biostatistics"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Professor,Natural Sciences Cluster - Statistics"}],"primaryAppointment":"Professor,Health Research & Policy - Biostatistics","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4688&type=small&showNoImage","displayName":"Robert Tibshirani","firstName":"Robert","href":"http://med.stanford.edu/profiles/Robert_Tibshirani","researchInterest":"My research is in applied statistics and biostatistics. I specialize in \u000bcomputer-intensive methods for regression and classification, bootstrap, cross-validation\u000band statistical inference, and signal and image analysis for medical diagnosis."},{"lastName":"Levy","clinicalFocus":[{"focus":"Lymphoma "},{"focus":"Non-Hodgkin's Lymphoma"},{"focus":"Non-Hodgkin's Lymphoma - Medical Oncology"},{"focus":"Burkitt's Lymphoma"},{"focus":"Burkitt's Lymphoma - Medical Oncology"},{"focus":"Hodgkin's Disease"},{"focus":"Hodgkin's Disease - Medical Oncology"},{"focus":"Burkitt's Lymphoma - Hematology"},{"focus":"Hodgkin's Disease - Hematology"},{"focus":"Oncology (Cancer)"},{"focus":"Non-Hodgkin's Lymphoma - Hematology"},{"focus":"Medical Oncology"}],"appointments":[{"appointment":"Professor,Medicine - Oncology"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4608&type=small&showNoImage","displayName":"Ronald Levy, MD","firstName":"Ronald","href":"http://med.stanford.edu/profiles/Ronald_Levy","researchInterest":"Clinical Interests: lymphoma. Research Interests: Immunology and molecular biology of lymphoid malignancy; molecular vaccines for cancer."},{"lastName":"Advani","clinicalFocus":[{"focus":"Burkitt's Lymphoma"},{"focus":"Burkitt's Lymphoma - Hematology"},{"focus":"Burkitt's Lymphoma - Medical Oncology"},{"focus":"Hodgkin's Disease"},{"focus":"Investigational Therapeutics"},{"focus":"Leptommeningeal Disease"},{"focus":"Lymphoma "},{"focus":"Mycosis Fungoides"},{"focus":"Non-Hodgkin's Lymphoma"},{"focus":"Oncology (Cancer)"},{"focus":"Plasmacytoma"},{"focus":"Waldenstrom's Macroglobulinemia "},{"focus":"Medical Oncology"}],"appointments":[{"appointment":"Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4018&type=small&showNoImage","displayName":"Ranjana Advani","firstName":"Ranjana","href":"http://med.stanford.edu/profiles/Ranjana_Advani","researchInterest":"Clinical investigation in Hodgkin's disease, non-Hodgkin's Lymphomas and cutaneous lymphomas.  Experimental therapeutics with novel chemotherapy and biologically targeted therapies.\r\n\r\nThe research program is highly collaborative with radiation oncology, industry, pathology and dermatology."},{"lastName":"Rosenberg","clinicalFocus":[{"focus":"Hodgkin's Disease"},{"focus":"Hodgkin's Disease - Hematology"},{"focus":"Hodgkin's Disease - Medical Oncology"},{"focus":"Lymphoma "},{"focus":"Medical Oncology"}],"appointments":[{"appointment":"Professor Emeritus,Medicine - Oncology"},{"appointment":"Emeritus Faculty, Acad Council,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor Emeritus,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4127&type=small&showNoImage","displayName":"Saul A Rosenberg","firstName":"Saul","href":"http://med.stanford.edu/profiles/Saul_Rosenberg","researchInterest":"Clinical Interests: Hodgkin's disease and non-Hodgkin's lymphomas Research Interests: clinical trials, clinical-pathological-biological correlations"},{"lastName":"van de Rijn","clinicalFocus":[{"focus":"Anatomic Pathology"},{"focus":"Sarcoma"}],"appointments":[{"appointment":"Professor - Med Center Line,Pathology"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Child Health Research Institute"}],"primaryAppointment":"Professor - Med Center Line,Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4008&type=small&showNoImage","displayName":"Matt van de Rijn","firstName":"Matt","href":"http://med.stanford.edu/profiles/Matt_van de Rijn","researchInterest":"Our research focuses on gene microarray analysis of human soft tissue tumors (sarcomas). In addition we work with tissue microarrays to characterize large numbers of novel antisera raised against peptides derived from genes found to be of interest during gene array analysis."},{"lastName":"Higgins","clinicalFocus":[{"focus":"Pathology and Laboratory Medicine"},{"focus":"Anatomic/Clinical Pathology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Pathology"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Associate Professor - Med Center Line,Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4038&type=small&showNoImage","displayName":"John Higgins","firstName":"John","href":"http://med.stanford.edu/profiles/John_Higgins","researchInterest":"I work as a diagnostic surgical pathologist doing translational research in renal neoplasia and medical renal disease and neoplastic and medical liver disease. Subspecialty areas of clinical interest include diagnostic immunohistochemistry, renal, hepatic and transplant pathology."},{"lastName":"Natkunam","clinicalFocus":[{"focus":"Hematopathology"},{"focus":"Pathology and Laboratory Medicine"},{"focus":"Anatomic Pathology"}],"appointments":[{"appointment":"Professor - Med Center Line,Pathology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=5929&type=small&showNoImage","displayName":"Yasodha Natkunam, M.D., Ph.D","firstName":"Yasodha","href":"http://med.stanford.edu/profiles/Yasodha_Natkunam","researchInterest":"My research interests focus on the identification and characterization of markers of diagnostic and prognostic importance in hematolymphoid neoplasia."},{"lastName":"Kohrt","clinicalFocus":[{"focus":"Oncology"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Medicine - Oncology"}],"primaryAppointment":"Assistant Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=10873&type=small&showNoImage","displayName":"Holbrook Kohrt","firstName":"Holbrook","href":"http://med.stanford.edu/profiles/Holbrook_Kohrt","researchInterest":"My research is focused on developing novel therapeutic strategies to enhance anti-tumor immunity. Investigation of preclinical models of bone marrow transplantation and immunomodulatory antibody therapy provides the platform for translation to early phase clinical trials."},{"lastName":"Schwartz","clinicalFocus":[{"focus":"Pathology"},{"focus":"Anatomic Pathology"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Pathology"}],"primaryAppointment":"Assistant Professor - Med Center Line,Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=6794&type=small&showNoImage","displayName":"Erich Schwartz","firstName":"Erich","href":"http://med.stanford.edu/profiles/Erich_Schwartz","researchInterest":""},{"lastName":"Glaser","clinicalFocus":[],"appointments":[{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Member,Stanford Cancer Institute","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=7426&type=small&showNoImage","displayName":"Sally Glaser","firstName":"Sally","href":"http://med.stanford.edu/profiles/Sally_Glaser","researchInterest":"Dr. Glaser\u0092s interests in cancer epidemiology focus primarily on Hodgkin lymphoma, breast cancer, and Surveillance Research (the use of population-based cancer and other data to monitor cancer occurrence and related population patterns).  In these areas, her work addresses cancer etiology and outcomes related to several risk factors, including EBV and HIV."},{"lastName":"Cornbleet","clinicalFocus":[],"appointments":[{"appointment":"Emeritus Faculty-Med Ctr Line,Pathology"}],"primaryAppointment":"Emeritus Faculty-Med Ctr Line,Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4109&type=small&showNoImage","displayName":"Phyllis Cornbleet","firstName":"Phyllis","href":"http://med.stanford.edu/profiles/Phyllis_Cornbleet","researchInterest":"As medical director of the Hematology Laboratory, my main focus is service work, including laboratory administration, bone marrow pathology, and flow cytometry interpretation. Publications arise primarily from development or evaluation of laboratory methods or collections of unusual patient cases."},{"lastName":"Green","clinicalFocus":[],"appointments":[{"appointment":"Instructor,Medicine - Oncology"}],"primaryAppointment":"Instructor,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=23068&type=small&showNoImage","displayName":"Michael R. Green","firstName":"MIchael","href":"http://med.stanford.edu/profiles/MIchael_Green","researchInterest":""},{"lastName":"Ji","clinicalFocus":[{"focus":"Medical Oncology"},{"focus":"Oncology (Cancer)"},{"focus":"Gastrointestinal Neoplasms"},{"focus":"Inherited Cancer Disorders"}],"appointments":[{"appointment":"Assistant Professor,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Assistant Professor,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=5887&type=small&showNoImage","displayName":"Hanlee P. Ji","firstName":"Hanlee","href":"http://med.stanford.edu/profiles/Hanlee_Ji","researchInterest":"Cancer genomics and genetics, translational applications of next generation sequencing technologies, development of molecular signatures as prognostic and predictive biomarkers in oncology, primary genomic and proteomic technology development"},{"lastName":"Gratzinger","clinicalFocus":[{"focus":"Pathology"},{"focus":"Anatomic/Clinical Pathology"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Pathology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Assistant Professor - Med Center Line,Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=8154&type=small&showNoImage","displayName":"Dita Gratzinger","firstName":"Dita","href":"http://med.stanford.edu/profiles/Dita_Gratzinger","researchInterest":"I have two major research interests: the pre-leukemic bone marrow failure disorder myelodysplastic syndrome, or MDS; and the role of vascular endothelial growth factor (VEGFR) signaling in lymphoma.  I have developed a novel protocol to quantitate protein expression in a cell-lineage-specific pattern in intact bone marrow using a combination of multiple immunofluorescence on tissue microarrays, semi-automated high resolution image scanning, and sophisticated image analysis."},{"lastName":"Coutre","clinicalFocus":[{"focus":"Hematology"},{"focus":"Leukemia"},{"focus":"Chronic Lymphocytic Leukemia"},{"focus":"Multiple Myeloma"},{"focus":"Acute Myelogenous Leukemia"},{"focus":"Acute Lymphoblastic Leukemia"},{"focus":"Chronic Myeloid Leukemias"},{"focus":"Plasmacytoma"},{"focus":"Idiopathic Hypereosinophillic Syndrome"}],"appointments":[{"appointment":"Professor - Med Center Line,Medicine - Hematology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Medicine - Hematology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4695&type=small&showNoImage","displayName":"Steven Coutre","firstName":"Steven","href":"http://med.stanford.edu/profiles/Steven_Coutre","researchInterest":"My research integrates clinical care of patients with novel treatments for a variety of hematologic disorders.  I see patients with a wide range of problems with a particular focus on chronic lymphocytic leukemia and multiple myeloma.  I provide comprehensive consultative services as well as treatment for both the acute and chronic leukemias as well as non-malignant conditions such as clotting disorders and thrombocytopenia."},{"lastName":"Aghaee Pour","clinicalFocus":[],"appointments":[{"appointment":"Postdoctoral Research fellow, Microbiology & Immunology"}],"primaryAppointment":"Postdoctoral Research fellow, Microbiology & Immunology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=37521&type=small&showNoImage","displayName":"Nima Aghaee Pour","firstName":"Nima","href":"http://med.stanford.edu/profiles/Nima_Aghaee Pour","researchInterest":""},{"lastName":"Amylon","clinicalFocus":[{"focus":"Ped Hematology/Oncology"},{"focus":"Hematology/Oncology"}],"appointments":[{"appointment":"Professor Emeritus,Pediatrics - Stem Cell Transplantation"},{"appointment":"Emeritus Faculty-Med Ctr Line,Pediatrics - Stem Cell Transplantation"}],"primaryAppointment":"Professor Emeritus,Pediatrics - Stem Cell Transplantation","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=6097&type=small&showNoImage","displayName":"Michael Amylon","firstName":"Michael","href":"http://med.stanford.edu/profiles/Michael_Amylon","researchInterest":"Bone marrow transplantation (BMT) is a treatment modality which is being broadly applied to a growing number of disorders. Increasing success with BMT is offering improved survival to pediatric and adult patients with acute leukemia, chronic leukemia, lymphomas, and a variety of solid tumors as well as severe aplastic anemia."},{"lastName":"Frankovich","clinicalFocus":[{"focus":"Pediatric Rheumatology"}],"appointments":[{"appointment":"Clinical Assistant Professor,Pediatrics - Rheumatology"}],"primaryAppointment":"Clinical Assistant Professor,Pediatrics - Rheumatology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=6717&type=small&showNoImage","displayName":"Jennifer Frankovich","firstName":"Jennifer","href":"http://med.stanford.edu/profiles/Jennifer_Frankovich","researchInterest":""},{"lastName":"Pachynski","clinicalFocus":[{"focus":"Genitourinary Cancer"},{"focus":"Oncology"},{"focus":"Immunotherapy"},{"focus":"Prostate Cancer"}],"appointments":[{"appointment":"Instructor,Medicine - Oncology"}],"primaryAppointment":"Instructor,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=9589&type=small&showNoImage","displayName":"Russell K Pachynski, MD","firstName":"Russell","href":"http://med.stanford.edu/profiles/Russell_Pachynski","researchInterest":"The recruitment of key effector immune cells to the tumor microenvironment is critical for improving outcomes in cancer treatment. Our research has focused on evaluation of a novel leukocyte chemoattractant, chemerin. We have shown it can act as a tumor suppressive cytokine by marshaling the host immune system and skewing the number and ratio of key anti-tumor effector cells at the site of tumor. We are continuing our preclinical studies of chemerin, and plan to expand the general approach."},{"lastName":"Alizadeh","clinicalFocus":[{"focus":"Oncology"},{"focus":"Lymphoma"},{"focus":"B-Cell Chronic Lymphocytic Leukemia"},{"focus":"Waldenstrom Macroglobulinemia"},{"focus":"Burkitt Lymphoma"},{"focus":"Follicular Lymphoma"},{"focus":"Diffuse Large-Cell Lymphomas"},{"focus":"Leukemia, Hairy Cell"},{"focus":"Lymphoma, B-Cell, Marginal Zone"},{"focus":"Hodgkin Disease"}],"appointments":[{"appointment":"Assistant Professor,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Member,Child Health Research Institute"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Assistant Professor,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=9558&type=small&showNoImage","displayName":"Ash A. Alizadeh, MD/PhD","firstName":"Arash","href":"http://med.stanford.edu/profiles/Arash_Alizadeh","researchInterest":"My research is focused on attaining a better understanding of the initiation, maintenance, and progression of lymphoid tumors, and their response to immunochemotherapy toward improving current treatment strategies.  \r\n\r\nIn this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.  I hope to apply this knowledge towards the design of clinical trials in the treatment of patients with lymphoma, leukemia, and myeloma."},{"lastName":"Torchia","clinicalFocus":[],"appointments":[{"appointment":"MD Student, School of Medicine"},{"appointment":"Ph.D., Dean's Office"}],"primaryAppointment":"MD Student, School of Medicine","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=18055&type=small&showNoImage","displayName":"James Torchia","firstName":"James","href":"http://med.stanford.edu/profiles/James_Torchia","researchInterest":""},{"lastName":"Medeiros","clinicalFocus":[{"focus":"Hematology"},{"focus":"Acute leukemia"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Medicine - Hematology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Assistant Professor - Med Center Line,Medicine - Hematology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=7743&type=small&showNoImage","displayName":"Bruno Medeiros","firstName":"Bruno","href":"http://med.stanford.edu/profiles/Bruno_Medeiros","researchInterest":"My clinical activities combine the development of novel therapeutic modalities, translational research activities and epidemiological study of acute leukemia. My special focus is on the development of better, patient tailored therapies for young and elderly patients with acute leukemia."}]}